Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
How do you treat a focal pericardial metastasis?
For a focal pericardial metastasis being treated with high-dose SBRT, what is your standard practice for:
1. GTV to PTV Margin (specifically for motion and gating)?
2. Heart OAR Constraints?
Related Questions
Would you consider elective neck nodal irradiation for a large >5 cm head and neck extramedullary solitary plasmacytoma arising from the nasal cavity?
In light of Aizer et al. data presented at ASCO 2025, what is your threshold for offering SRS/SRT in patients with multiple brain metastases?
How would you treat an isolated para-aortic recurrence while receiving adjuvant pembrolizumab after definitive chemoradiation for cervical cancer?
Can palliative radiation be used to treat recurrent malignant pleural effusion in NSCLC?
How would you manage a patient who developed an intraprostatic abscess after SpaceOAR injection, prior to starting radiation?
When treating chestwall + RNI with VMAT, how much do you crop the PTV into lung as is done with the PTVeval in 3D contouring guides?
Would you offer partial breast radiation to a young breast cancer patient with BRCA 1 if all other criteria are met?
Do you constrain heterogeneity or hotspots when delivering spine SBRT for bone metastases?
If a patient with initially borderline resectable pancreatic cancer receives neoadjuvant CHT followed by CRT and is ultimately deemed unresectable, do you consider an RT boost?
Given that ESOPEC did not mandate PET staging, are the conclusions of the study still applicable for patients who are staged with PET?